Roseomonas infection associated with a left ventricular assist device.
Roseomonas species have been increasingly noted as causes of human infection. We present what we believe is the first case of left ventricular assist device (LVAD) infection secondary to Roseomonas. The clinical characteristics of Roseomonas infection and the pertinent features of LVAD infection are reviewed.
Singal
Amit
A
University of Michigan Medical School, Ann Arbor, USA.
Malani
Preeti N
PN
Day
Larry J
LJ
Pagani
Francis D
FD
Clark
Nina M
NM
D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001022:Aortic Valve Insufficiency / Q000150:complications; D009202:Cardiomyopathies / Q000150:complications; D002444:Cefuroxime / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D016027:Heart Transplantation; D006353:Heart-Assist Devices / Q000009:adverse effects / Q000382:microbiology*; D006801:Humans; D042082:Methylobacteriaceae / Q000187:drug effects / Q000302:isolation & purification*; D008824:Michigan; D008875:Middle Aged; D013407:Sulbactam / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; C035444:sultamicillin; D000667:Ampicillin; D002444:Cefuroxime; D013407:Sulbactam